| Atsena Therapeutics Doses First Patient and Reports Rapid Early Enrollment in Pivotal Trial of ATSN-201 for X-Linked Retinoschisis |
Globe Newswire |
06/22 |
08:00 |
| Medidata Unveils New Academic Board to Bridge the Gap Between Research and Patient Care |
Globe Newswire |
06/22 |
08:00 |
| Skyborne Technology, Inc (STI), a UAV Corp Company, completes initial step for Weight Balance Analysis and Flight Testing |
Globe Newswire |
06/22 |
08:00 |
| Kandi Technologies Accelerates Global Expansion |
Globe Newswire |
06/22 |
08:00 |
| Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D. |
Globe Newswire |
06/22 |
08:00 |
| ASML reports transactions under its current share buyback program |
Globe Newswire |
06/22 |
08:00 |
| NorthStar Secures Over CAD$40M with 3 Canadian Space Division to Advance Sovereign Space Domain Awareness |
Globe Newswire |
06/22 |
08:00 |
| Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) |
Globe Newswire |
06/22 |
08:00 |
| EagleNXT Secures Order of eBee VISION ISR and eBee TAC Systems from Asia Pacific Customer |
Globe Newswire |
06/22 |
08:00 |
| Westport Announces US$10 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules |
Globe Newswire |
06/22 |
08:00 |
| Praxis Precision Medicines Receives FDA Breakthrough Therapy Designation for Elsunersen for the Treatment of Seizures Associated with SCN2A Developmental and Epileptic Encephalopathy Caused by Gain of Function Variants |
Globe Newswire |
06/22 |
08:00 |
| NordLayer Named a Winner in the Expert Insights Cybersecurity Awards Summer 2026 for Network Security |
Globe Newswire |
06/22 |
08:00 |
| Veea Strengthens Executive Leadership Team to Accelerate its Commercial Growth and Market Expansion |
Globe Newswire |
06/22 |
08:00 |
| Prolium Bioscience Announces First Patient Dosed in its Multinational, Phase 1/2 Study of PRO-203 in Systemic Sclerosis, and Last Patient, Last Visit in an Investigator-Led Study of PRO-203 in Refractory Lupus Nephritis |
Globe Newswire |
06/22 |
08:00 |
| Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome |
Globe Newswire |
06/22 |
08:00 |
| Catheter Precision, Inc. Announces Allowance of Key Intellectual Property |
Globe Newswire |
06/22 |
08:00 |
| Amaero Expands Powder Capacity Ahead of Schedule |
Globe Newswire |
06/22 |
08:00 |
| Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum |
Globe Newswire |
06/22 |
08:00 |
| Castor Maritime Inc. Announces Vessel Acquisition |
Globe Newswire |
06/22 |
07:45 |
| "Northeast Super League" Ignites Dalian as the City's First Home Match Makes an Eagerly-Anticipated Debut |
Globe Newswire |
06/22 |
07:44 |
| Irby Celebrates 100 Years of Growth, Partnership and Industry Leadership |
Globe Newswire |
06/22 |
07:41 |
| St. Augustine Dentist Explains Why Replacing Missing Teeth Can Support Long-Term Oral Health |
Globe Newswire |
06/22 |
07:38 |
| Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds |
Globe Newswire |
06/22 |
07:30 |
| TETmedical Receives FDA Breakthrough Device Designation for NSE-FAST®, the First Rapid Test Designed to Aid in the Diagnosis of Acute Ischemic Stroke |
Globe Newswire |
06/22 |
07:30 |
| BridgeBio to Present Primary Results from Phase 3 PROPEL 3 Trial of Oral Infigratinib for Children Living with Achondroplasia at ICCBH 2026 |
Globe Newswire |
06/22 |
07:30 |
